Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Tianjin Zhongxin Pharmaceutical Group Corp Ltd

T14
Current price
2.33 USD 0 USD (0.00%)
Last closed 34.01 CNY
ISIN CNE000001808
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Singapore Stock Exchange
Capitalization 22 724 605 949 CNY
Yield for 12 month +9.62 %
1Y
3Y
5Y
10Y
15Y
T14
21.11.2021 - 28.11.2021

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People's Republic of China. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; and biochemical pharmaceutical products, as well as wholesale and retail sale of medicines. Its products include Suxiao Jiuxin Pills, Jingwanhong Ointment, Biqi Capsules, Shunaoxin Dropping Pills, Zilongjin Tablets, Qingfei Xiaoyan Pills, Huoxiangzhengqi Soft Capsules, Tongmai Yangxin Pills, Weichangan Pills, Qingyan Dropping Pills, Haima Bushen Pills, Angong Niuhuang Pills, Niuhuang Qingxin Pills, Qinggong Shoutao Pills, etc. The company also engages in pharmaceutical commercial logistic services; pharmaceuticals retail; chemical raw materials and preparations; and biomedicine. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was founded in 1981 and is based in Tianjin, the People's Republic of China. Address: Darentang Building, Tianjin, China, 300193

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

331.25 CNY

P/E ratio

28.0661

Dividend Yield

Current Year

+8 222 311 852 CNY

Last Year

+8 249 249 566 CNY

Current Quarter

+1 646 191 770 CNY

Last Quarter

+1 879 152 395 CNY

Current Year

+3 618 228 450 CNY

Last Year

+3 293 657 689 CNY

Current Quarter

+767 915 577 CNY

Last Quarter

+904 619 489 CNY

Key Figures T14

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 923 832 575 CNY
Operating Margin TTM 9 %
PE Ratio 28.0661
Return On Assets TTM 4.69 %
PEG Ratio
Return On Equity TTM 14.18 %
Wall Street Target Price 331.25 CNY
Revenue TTM 8 040 204 800 CNY
Book Value 8.34 CNY
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -3.4 %
Dividend Yield
Gross Profit TTM 2 746 778 973 CNY
Earnings per share 1.21 CNY
Diluted Eps TTM 1.21 CNY
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 9.2 %
Profit Margin 11.6 %

Dividend Analytics T14

Dividend growth over 5 years

460 %

Continuous growth

2 years

Payout Ratio 5 years average

36 %

Dividend History T14

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 12.07.2024
Forward Annual Dividend Yield
Last Split Factor 2:1
Payout Ratio 105.79 %
Last Split Date 05.07.2010
Dividend Date

Stock Valuation T14

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 28.0661
Forward PE
Enterprise Value Revenue 2.8096
Price Sales TTM 2.8239
Enterprise Value EBITDA 20.6275
Price Book MRQ 4.0799

Financials T14

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators T14

For 52 weeks

23.4 CNY 39.05 CNY
50 Day MA 32.5 CNY
Shares Short Prior Month
200 Day MA 32.17 CNY
Short Ratio
Shares Short
Short Percent